EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA damage induced PARP ‐1 overactivation confers paclitaxel‐induced neuropathic pain by regulating mitochondrial oxidative metabolism

Meng-Meng Ge iD, Jun-Jie Hu, Ya-Qun Zhou, Yu-Ke Tian, Zhi-Heng Liu, Hui Yang, Yi-Rong Zhou, Qiu Qiu, Da-Wei Ye iD

CNS Neuroscience & Therapeutics · 2024-09 · 30 (9)

DOI: 10.1111/cns.70012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 30.08.2024. Verfasst von Meng-Meng Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: DNA Damage, Mitochondria, Neuralgia, Paclitaxel. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Poly (ADP‐ribose) polymerase (PARP) has been extensively investigated in human cancers. Recent studies verified that current available PARP inhibitors (Olaparib or Veliparib) provided clinical palliation of clinical patients suffering from paclitaxel‐induced neuropathic pain (PINP). However, the underlying mechanism of PARP overactivation in the development of PINP remains to be investigated. Methods and Results We reported induction of DNA oxidative damage, PARP‐1 overactivation, and subsequent nicotinamide adenine dinucleotide (NAD + ) depletion as crucial events in the pathogenesis of PINP. Therefore, we developed an Olaparib PROTAC to achieve the efficient degradation of PARP. Continuous intrathecal injection of Olaparib PROTAC protected against PINP by inhibiting the activity of PARP‐1 in rats. PARP‐1, but not PARP‐2, was shown to be a crucial enzyme in the development of PINP. Specific inhibition of PARP‐1 enhanced mitochondrial redox metabolism partly by upregulating the expression and deacetylase activity of sirtuin‐3 (SIRT3) in the dorsal root ganglions and spinal cord in the PINP rats. Moreover, an increase in the NAD + level was found to be a crucial mechanism by which PARP‐1 inhibition enhanced SIRT3 activity.

Conclusion

The findings provide a novel insight into the mechanism of DNA oxidative damage in the development of PINP and implicate PARP‐1 as a possible therapeutic target for clinical PINP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA DamageMitochondriaNeuralgiaPaclitaxelPoly (ADP-Ribose) Polymerase-1AnimalsMaleRatsDisease Models, AnimalGanglia, SpinalNADOxidative StressPhthalazinesPiperazinesPoly(ADP-ribose) Polymerase InhibitorsRats, Sprague-DawleySpinal Cord

Stichwörter der Autor:innen

Olaparib PROTACPARP‐1Sirt‐3oxidative metabolismpaclitaxel‐induced neuropathic pain

Substanzen

NADolaparibPaclitaxelParp1 protein, ratPhthalazinesPiperazinesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Anesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Anesthesiology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, China.
  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Anaesthesiology, Queen Mary Hospital, Hong Kong, Special Administrative Region, Hong Kong, China.

ORCID-Profile: Meng-Meng Ge, Da-Wei Ye

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, M. M., Hu, J. J., Zhou, Y. Q., Tian, Y. K., Liu, Z. H., Yang, H., Zhou, Y. R., Qiu, Q., & Ye, D. W. (2024). DNA damage induced PARP ‐1 overactivation confers paclitaxel‐induced neuropathic pain by regulating mitochondrial oxidative metabolism. CNS Neuroscience & Therapeutics, 30(9). https://doi.org/10.1111/cns.70012

Vancouver

Ge MM, Hu JJ, Zhou YQ, Tian YK, Liu ZH, Yang H, et al. DNA damage induced PARP ‐1 overactivation confers paclitaxel‐induced neuropathic pain by regulating mitochondrial oxidative metabolism. CNS Neuroscience & Therapeutics. 2024;30(9). doi:10.1111/cns.70012

BibTeX
@article{Ge2024,
  author = {Ge, Meng-Meng and Hu, Jun-Jie and Zhou, Ya-Qun and Tian, Yu-Ke and Liu, Zhi-Heng and Yang, Hui and Zhou, Yi-Rong and Qiu, Qiu and Ye, Da-Wei},
  title = {DNA damage induced PARP ‐1 overactivation confers paclitaxel‐induced neuropathic pain by regulating mitochondrial oxidative metabolism},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {9},
  doi = {10.1111/cns.70012}
}
Kostenlos starten →